{"entity":{"type":"insider","cik":"0001417915","url":"/insider/0001417915","json_url":"/insider/0001417915.json","name":"Price Ben Gil","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":11,"n_filings":10,"first":"2008-08-19","last":"2019-01-31","span_basis":"filed_date"},"name_variants":[{"name":"Price Ben Gil","source":"filing","n_filings":10,"first_seen":"2008-08-19","last_seen":"2019-01-31"}],"transactions":[{"id":7864454,"accession":"0001140361-19-002082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-19-002082","line_url":"/filing/0001140361-19-002082#line-1","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001417915","owner_name":"Price Ben Gil","owner_display_name":"Price Ben Gil","owner_url":"/insider/0001417915","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":0.6094,"price_display":"0.61","price_state":"stated","total_value":9141.0,"total_display":"9,141.00","total_whole":"9,141","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-29","filed_date":"2019-01-31","scope":"insider"},{"id":2923087,"accession":"0001209191-16-108952","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-108952","line_url":"/filing/0001209191-16-108952#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001417915","owner_name":"Price Ben Gil","owner_display_name":"Price Ben Gil","owner_url":"/insider/0001417915","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4500.0,"shares_display":"4,500","price_per_share":16.6987,"price_display":"16.70","price_state":"stated","total_value":75144.15,"total_display":"75,144.15","total_whole":"75,144","shares_owned_after":42830.0,"shares_owned_after_display":"42,830","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-03-14","filed_date":"2016-03-16","scope":"insider"},{"id":5205931,"accession":"0001181431-13-045716","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-045716","line_url":"/filing/0001181431-13-045716#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001417915","owner_name":"Price Ben Gil","owner_display_name":"Price Ben Gil","owner_url":"/insider/0001417915","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":31.175,"price_display":"31.18","price_state":"stated","total_value":15587.5,"total_display":"15,587.50","total_whole":"15,588","shares_owned_after":35330.0,"shares_owned_after_display":"35,330","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-19","filed_date":"2013-08-20","scope":"insider"},{"id":2993986,"accession":"0000873303-12-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000873303-12-000003","line_url":"/filing/0000873303-12-000003#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"AVI BIOPHARMA INC","issuer_ticker":"AVII","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001417915","owner_name":"Price Ben Gil","owner_display_name":"Price Ben Gil","owner_url":"/insider/0001417915","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":1.295,"price_display":"1.30","price_state":"stated","total_value":38850.0,"total_display":"38,850.00","total_whole":"38,850","shares_owned_after":197982.0,"shares_owned_after_display":"197,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-14","filed_date":"2012-03-15","scope":"insider"},{"id":8991456,"accession":"0000873303-11-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000873303-11-000014","line_url":"/filing/0000873303-11-000014#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"AVI BIOPHARMA INC","issuer_ticker":"AVII","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001417915","owner_name":"Price Ben Gil","owner_display_name":"Price Ben Gil","owner_url":"/insider/0001417915","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":1.5,"price_display":"1.50","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","total_whole":"30,000","shares_owned_after":162982.0,"shares_owned_after_display":"162,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-04-06","filed_date":"2011-04-06","scope":"insider"},{"id":7719939,"accession":"0000873303-10-000050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000873303-10-000050","line_url":"/filing/0000873303-10-000050#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"AVI BIOPHARMA INC","issuer_ticker":"AVII","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001417915","owner_name":"Price Ben Gil","owner_display_name":"Price Ben Gil","owner_url":"/insider/0001417915","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":1.93,"price_display":"1.93","price_state":"stated","total_value":7720.0,"total_display":"7,720.00","total_whole":"7,720","shares_owned_after":102982.0,"shares_owned_after_display":"102,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-13","filed_date":"2010-08-16","scope":"insider"},{"id":7597658,"accession":"0000873303-10-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000873303-10-000027","line_url":"/filing/0000873303-10-000027#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"AVI BIOPHARMA INC","issuer_ticker":"AVII","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001417915","owner_name":"Price Ben Gil","owner_display_name":"Price Ben Gil","owner_url":"/insider/0001417915","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":1.44,"price_display":"1.44","price_state":"stated","total_value":10080.0,"total_display":"10,080.00","total_whole":"10,080","shares_owned_after":98982.0,"shares_owned_after_display":"98,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-11","filed_date":"2010-06-11","scope":"insider"},{"id":7411701,"accession":"0001257957-10-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001257957-10-000018","line_url":"/filing/0001257957-10-000018#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"AVI BIOPHARMA INC","issuer_ticker":"AVII","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001417915","owner_name":"Price Ben Gil","owner_display_name":"Price Ben Gil","owner_url":"/insider/0001417915","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":1.36,"price_display":"1.36","price_state":"stated","total_value":54400.0,"total_display":"54,400.00","total_whole":"54,400","shares_owned_after":126982.0,"shares_owned_after_display":"126,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-05-13","filed_date":"2010-05-13","scope":"insider"},{"id":5789951,"accession":"0001257957-09-000021","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001257957-09-000021","line_url":"/filing/0001257957-09-000021#line-2","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"AVI BIOPHARMA INC","issuer_ticker":"AVII","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001417915","owner_name":"Price Ben Gil","owner_display_name":"Price Ben Gil","owner_url":"/insider/0001417915","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20400.0,"shares_display":"20,400","price_per_share":0.6717,"price_display":"0.67","price_state":"stated","total_value":13702.68,"total_display":"13,702.68","total_whole":"13,703","shares_owned_after":81982.0,"shares_owned_after_display":"81,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-16","filed_date":"2009-03-17","scope":"insider"},{"id":5789950,"accession":"0001257957-09-000021","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001257957-09-000021","line_url":"/filing/0001257957-09-000021#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"AVI BIOPHARMA INC","issuer_ticker":"AVII","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001417915","owner_name":"Price Ben Gil","owner_display_name":"Price Ben Gil","owner_url":"/insider/0001417915","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":30000.0,"shares_display":"30,000","price_per_share":0.6459,"price_display":"0.65","price_state":"stated","total_value":19377.0,"total_display":"19,377.00","total_whole":"19,377","shares_owned_after":61582.0,"shares_owned_after_display":"61,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-03-13","filed_date":"2009-03-17","scope":"insider"},{"id":3957444,"accession":"0001257957-08-000040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001257957-08-000040","line_url":"/filing/0001257957-08-000040#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"AVI BIOPHARMA INC","issuer_ticker":"AVII","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001417915","owner_name":"Price Ben Gil","owner_display_name":"Price Ben Gil","owner_url":"/insider/0001417915","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6582.0,"shares_display":"6,582","price_per_share":1.22,"price_display":"1.22","price_state":"stated","total_value":8030.04,"total_display":"8,030.04","total_whole":"8,030","shares_owned_after":31582.0,"shares_owned_after_display":"31,582","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-08-15","filed_date":"2008-08-19","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":11,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":11,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":11},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001228627","name":"REXAHN PHARMACEUTICALS, INC.","url":"/issuer/0001228627","role":"Director","n_filings":1,"first_seen":"2019-01-31","last_seen":"2019-01-31"},{"type":"issuer","type_label":"ISSUER","cik":"0000873303","name":"Sarepta Therapeutics, Inc.","url":"/issuer/0000873303","role":"Director","n_filings":9,"first_seen":"2008-08-19","last_seen":"2016-03-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001417915","retrieved_at":"2026-08-27T11:01:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}